The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance

Not Applicable

Completed

• Conditions: Dry Eye
• Interventions: Other: Systane Ultra Lubricant Eye Drops; Other: Optive Lubricant Eye Drops

• Registration Number: NCT00673764
• Lead Sponsor: Alcon Research

Brief Summary

To evaluate the effect of 2 different lubricant eye drops on visual function of patients with dry eye

Detailed Description

Not available

Study Timeline

• Study Start: 2008-05
• Study First Submitted: 2008-05-02
• Study First Submitted QC: 2008-05-06
• Study First Posted: 2008-05-07
• Primary Completion: 2008-06
• Study Completion: 2008-06
• Results First Submitted: 2009-09-18
• Results First Submitted QC: 2010-01-22
• Results First Posted: 2010-02-10
• Status Verified: 2012-01
• Last Update Submitted: 2012-01-31
• Last Update Posted: 2012-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Documented diagnosis of dry eye
• Must not have worn contact lenses for 12 hours prior to Day 1

Exclusion Criteria

• Age related

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Systane Ultra	Systane Ultra Lubricant Eye Drops	Systane Ultra Lubricant Eye Drops
Optive	Optive Lubricant Eye Drops	Optive Lubricant Eye Drops

Primary Outcome Measures

Name	Time	Method
Time at Best Corrected Visual Acuity	15 minutes, 45 minutes, and 90 minutes post-dose	Measuring length of time patient can maintain their best vision while completing a computer task. Performed at 15 minutes, 45 minutes, and 90 minutes post-dose. Corrected visual acuity means the patient can wear glasses or contacts if needed such that the measure is performed with the patient seeing the best that they can.

Secondary Outcome Measures

Name	Time	Method
Functional Blink Rate Time (Time Between Blinks)	15 minutes, 45 minutes, and 90 minutes post-dose	Measures time in seconds between normal blinks. Performed at 15 minutes, 45 minutes, and 90 minutes post-dose. Longer blink rate time correlates with improved visual performance.

Trial Locations

Locations (1)

North Andover; 🇺🇸 North Andover, Massachusetts, United States